0000899243-22-019219.txt : 20220523 0000899243-22-019219.hdr.sgml : 20220523 20220523165448 ACCESSION NUMBER: 0000899243-22-019219 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220519 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRATTAROLI JOSEPH CENTRAL INDEX KEY: 0001272668 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 22952494 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-19 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001272668 FRATTAROLI JOSEPH 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 0 1 0 0 Chief Financial Officer Common Stock 2022-05-19 4 P 0 3948 0.644 A 48091 D /s/ Joseph Frattaroli 2022-05-23